‘四位一体’方案，让老烂腿愈合更快(上篇）

字号 + –

18 10月 2019

1
2
3
4
5

Author : 伤口世界

原创：胡海涛负压引流与创面修复

77岁的老烂腿，如果想在短时间内治愈，几乎是不可能的事情！

它涉及四个重要问题：

1.让水肿、感染的伤口变得清洁；

2.缺损皮肤修复；

3.下肢静脉曲张手术治疗；

4.小腿色素沉着、肿胀，需要压力治疗。

如何同时解决以上四个问题，才是它快速愈合的基础！

经过10年经验总结，制定个体化治疗方案：负压引流+植皮+微创处理曲张血管，预计时间2-3周，分阶段处理；

第一阶段：予小腿溃疡使用改良封闭式负压引流，待创面感染控制、肉芽红润后进入二阶段

第二阶段：给予下肢静脉曲张高位结扎+局部硬化剂注射+点状植皮术

然后负压引流：

再弹力绷带加压包扎治疗：

第三阶段：植皮成活后，患者出院前：

小腿颜色明显变浅，皮片成活并开始爬行，患者回当地，自己换药处理。

‘四位一体’治疗静脉曲张型老烂腿方案总结：

第一位：早期负压引流处理；
第二位：微创处理血管；
第三位：点状植皮+封闭式负压引流
第四位：压力治疗

一体：整体治疗，同时推进症状和病因处理，创伤小、时间短、费用低、疗效确切。

569 Views

伤口世界

电子邮件地址该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

Latest from 伤口世界

K2 Content

Diabetes remission in the real world 2024-09-20 00:00

Pam Brown

GP in Swansea

Citation: Brown P (2024) Diabetes Distilled: Diabetes remission in the real world. Diabetes & Primary Care 26: 145–7

Diabetes remission is achievable at scale in the real world, according to early results from the NHS Type 2 Diabetes Path to Remission programme published in Lancet Diabetes & Endocrinology. Of 7540 people referred to the programme between September 2020 and December 2022, a total of 1740 started the total diet replacement section of the programme before January 2022, and 960 (55%) completed the programme. Mean weight loss for the 1710 who started the programme and had follow-up data available was 9.4 kg (8.3%), with a mean weight loss of 10.3 kg (9.3%) among the 945 who completed the programme. Amongst the 945 who completed the programme and had two HbA1c measurements, 32% achieved remission, with mean weight loss of 15.9 kg (14.4%), while overall 27% of those who started the programme achieved remission regardless of whether they completed. Remission rates are lower than in trials such as DiRECT and DIADEM-I, despite similar levels of weight loss. The authors highlight that an additional 17% of participants met the HbA1c targets for remission but continued on metformin and may otherwise have achieved remission. These early results confirm that type 2 diabetes remission is indeed possible at scale in the real world, outside of clinical trials.
Impact of metformin timing on glucose and GLP-1 response 2024-09-19 00:00

Pam Brown GP in Swansea

Citation: Brown P (2024) Diabetes Distilled: Impact of metformin timing on glucose and GLP-1 response. Diabetes & Primary Care 26: 143–4

Glucose-lowering effects in response to normal-release metformin are greater when the drug is given 30 or 60 minutes before, rather than with, food, according to this small study in people with well-controlled type 2 diabetes published in Diabetologia. Endogenous GLP-1 secretion increased when metformin 1000 mg was given 30 or 60 minutes prior to a glucose infusion, whereas there was no increase when the metformin was administered at the same time as the glucose. The results suggest that, if tolerated, administering standard release metformin before meals may lead to improved postprandial glycaemic control.
The importance of getting the correct diabetes diagnosis 2024-09-18 00:00

Jane Diggle Specialist Diabetes Nurse Practitioner, West Yorkshire

Citation: Diggle J (2024) The importance of getting the correct diabetes diagnosis. Diabetes & Primary Care 26: 111–2

Custom Mod Mega1

主任医师、教授、博导，南方医科大学第三附属医院（广东省骨科医院）院长